Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew A Coleman

Showing results (71-80 of 99) with videos related to

Pageof 10
Sort By:
Biomaterials|February 5, 2022
Extracellular matrix modulates T cell clearance of malignant cells in vitroClaire Robertson, Aimy Sebastian, Aubree Hinckley, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2024
Evaluation in mice of cell-free produced CT584 as a Chlamydia vaccine antigenSteven Hoang-Phou, Sukumar Pal, Anatoli Slepenkin, et al.
The Pediatric Infectious Disease Journal|July 2, 2019
Attitudes of Pregnant Women and Healthcare Professionals Toward Clinical Trials and Routine Implementation of Antenatal Vaccination Against Respiratory Syncytial Virus: A Multicenter Questionnaire StudyChristopher R Wilcox, Anna Calvert, Jane Metz, et al.
Protein Science : a Publication of the Protein Society|June 12, 2013
Controlling the diameter, monodispersity, and solubility of ApoA1 nanolipoprotein particles using telodendrimer chemistryWei He, Juntao Luo, Feliza Bourguet, et al.
Frontiers in Cardiovascular Medicine|July 11, 2022
Spaceflight-Associated Changes of snoRNAs in Peripheral Blood Mononuclear Cells and Plasma Exosomes-A Pilot StudyAmit Kumar Rai, K Shanmugha Rajan, Malik Bisserier, et al.
International Journal of Molecular Sciences|September 11, 2009
Characterization and purification of polydisperse reconstituted lipoproteins and nanolipoprotein particlesCraig D Blanchette, Brent W Segelke, Nicholas Fischer, et al.
Journal of Visualized Experiments : Jove|April 4, 2022
Cell-free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine DevelopmentSean F Gilmore, Wei He, Angela C Evans, et al.
Plos One|March 26, 2016
Expression and Association of the Yersinia pestis Translocon Proteins, YopB and YopD, Are Facilitated by Nanolipoprotein ParticlesMatthew A Coleman, Jenny A Cappuccio, Craig D Blanchette, et al.
Vaccines|October 26, 2024
CT584 Is Not a Protective Vaccine Antigen against Respiratory Chlamydial Challenge in MiceSteven Hoang-Phou, Sukumar Pal, Anatoli Slepenkin, et al.
Journal of Lipid Research|April 12, 2008
Quantifying size distributions of nanolipoprotein particles with single-particle analysis and molecular dynamic simulationsCraig D Blanchette, Richard Law, W Henry Benner, et al.
Pageof 10

Showing results (71-80 of 99) with videos related to

Sort By:
Pageof 10
Biomaterials|February 5, 2022
Extracellular matrix modulates T cell clearance of malignant cells in vitroClaire Robertson, Aimy Sebastian, Aubree Hinckley, et al.
Biorxiv : the Preprint Server for Biology|June 19, 2024
Evaluation in mice of cell-free produced CT584 as a Chlamydia vaccine antigenSteven Hoang-Phou, Sukumar Pal, Anatoli Slepenkin, et al.
The Pediatric Infectious Disease Journal|July 2, 2019
Attitudes of Pregnant Women and Healthcare Professionals Toward Clinical Trials and Routine Implementation of Antenatal Vaccination Against Respiratory Syncytial Virus: A Multicenter Questionnaire StudyChristopher R Wilcox, Anna Calvert, Jane Metz, et al.
Protein Science : a Publication of the Protein Society|June 12, 2013
Controlling the diameter, monodispersity, and solubility of ApoA1 nanolipoprotein particles using telodendrimer chemistryWei He, Juntao Luo, Feliza Bourguet, et al.
Frontiers in Cardiovascular Medicine|July 11, 2022
Spaceflight-Associated Changes of snoRNAs in Peripheral Blood Mononuclear Cells and Plasma Exosomes-A Pilot StudyAmit Kumar Rai, K Shanmugha Rajan, Malik Bisserier, et al.
International Journal of Molecular Sciences|September 11, 2009
Characterization and purification of polydisperse reconstituted lipoproteins and nanolipoprotein particlesCraig D Blanchette, Brent W Segelke, Nicholas Fischer, et al.
Journal of Visualized Experiments : Jove|April 4, 2022
Cell-free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine DevelopmentSean F Gilmore, Wei He, Angela C Evans, et al.
Plos One|March 26, 2016
Expression and Association of the Yersinia pestis Translocon Proteins, YopB and YopD, Are Facilitated by Nanolipoprotein ParticlesMatthew A Coleman, Jenny A Cappuccio, Craig D Blanchette, et al.
Vaccines|October 26, 2024
CT584 Is Not a Protective Vaccine Antigen against Respiratory Chlamydial Challenge in MiceSteven Hoang-Phou, Sukumar Pal, Anatoli Slepenkin, et al.
Journal of Lipid Research|April 12, 2008
Quantifying size distributions of nanolipoprotein particles with single-particle analysis and molecular dynamic simulationsCraig D Blanchette, Richard Law, W Henry Benner, et al.
Pageof 10